Published in Neurosurgery on September 01, 2005
"Syndrome of the sinking skin-flap" secondary to the ventriculoperitoneal shunt after craniectomy. J Korean Neurosurg Soc (2008) 1.01
Multimodal imaging of recovery of functional networks associated with reversal of paradoxical herniation after cranioplasty. Clin Imaging (2011) 0.84
Paradoxical transtentorial herniation caused by lumbar puncture after decompressive craniectomy. J Korean Neurosurg Soc (2012) 0.80
Emergent epidural blood patch: lifesaving treatment of paradoxical herniation. Arch Neurol (2009) 0.75
Paradoxical Herniation following Decompressive Craniectomy in the Subacute Setting. Case Rep Neurol Med (2016) 0.75
Radiological signs of the syndrome of the trephined. Neuroradiology (2016) 0.75
Lumbar puncture as possible cause of sudden paradoxical herniation in patient with previous decompressive craniectomy: report of two cases. BMC Neurol (2017) 0.75
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. Proc Natl Acad Sci U S A (2012) 4.20
Treatment and outcomes of acute basilar artery occlusion in the Basilar Artery International Cooperation Study (BASICS): a prospective registry study. Lancet Neurol (2009) 3.36
Arteriovenous malformations. Lancet (2002) 3.15
Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial. J Neurosurg (2005) 2.87
Akt contributes to neuroprotection by hypothermia against cerebral ischemia in rats. J Neurosci (2005) 2.53
Interrupting reperfusion as a stroke therapy: ischemic postconditioning reduces infarct size after focal ischemia in rats. J Cereb Blood Flow Metab (2006) 2.41
Cell transplantation therapy for stroke. Stroke (2007) 2.30
Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain. Brain (2011) 2.27
Profile of daily life in children with brain tumors: an assessment of health-related quality of life. J Clin Oncol (2005) 2.26
Phosphoinositide-3-kinase/akt survival signal pathways are implicated in neuronal survival after stroke. Mol Neurobiol (2006) 2.17
Sex differences in clinical presentation and treatment outcomes in Moyamoya disease. Neurosurgery (2012) 2.06
Long-term monitoring of transplanted human neural stem cells in developmental and pathological contexts with MRI. Proc Natl Acad Sci U S A (2007) 2.03
Neural stem cell engraftment and myelination in the human brain. Sci Transl Med (2012) 1.96
Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis. Hum Mol Genet (2008) 1.95
Sedation confounds outcome prediction in cardiac arrest survivors treated with hypothermia. Neurocrit Care (2011) 1.85
Moyamoya disease in pediatric patients: outcomes of neurosurgical interventions. Neurosurg Focus (2008) 1.84
Protein kinase C delta mediates cerebral reperfusion injury in vivo. J Neurosci (2004) 1.71
Bcl-2 overexpression protects against neuron loss within the ischemic margin following experimental stroke and inhibits cytochrome c translocation and caspase-3 activity. J Neurochem (2003) 1.69
Optimizing the success of cell transplantation therapy for stroke. Neurobiol Dis (2009) 1.61
Who's in favor of translational cell therapy for stroke: STEPS forward please? Cell Transplant (2009) 1.60
Thrombospondins 1 and 2 are necessary for synaptic plasticity and functional recovery after stroke. J Cereb Blood Flow Metab (2008) 1.59
Multimodality treatment of posterior fossa arteriovenous malformations. J Neurosurg (2008) 1.59
General versus specific actions of mild-moderate hypothermia in attenuating cerebral ischemic damage. J Cereb Blood Flow Metab (2007) 1.57
The Akt signaling pathway contributes to postconditioning's protection against stroke; the protection is associated with the MAPK and PKC pathways. J Neurochem (2008) 1.54
Neurogenesis in rats after focal cerebral ischemia is enhanced by indomethacin. Stroke (2005) 1.54
Transplanted stem cell-secreted vascular endothelial growth factor effects poststroke recovery, inflammation, and vascular repair. Stem Cells (2011) 1.54
Symptomatic intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke: a review of the risk factors. Cerebrovasc Dis (2007) 1.50
Spinal pilocytic astrocytoma in an elderly patient. World Neurosurg (2011) 1.49
Human neural stem cell grafts modify microglial response and enhance axonal sprouting in neonatal hypoxic-ischemic brain injury. Stroke (2010) 1.44
Progression of unilateral moyamoya disease: A clinical series. Cerebrovasc Dis (2006) 1.40
Adherent self-renewable human embryonic stem cell-derived neural stem cell line: functional engraftment in experimental stroke model. PLoS One (2008) 1.37
Glioblastoma multiforme: exploratory radiogenomic analysis by using quantitative image features. Radiology (2014) 1.36
Bcl-2 transfection via herpes simplex virus blocks apoptosis-inducing factor translocation after focal ischemia in the rat. J Cereb Blood Flow Metab (2004) 1.36
Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article. J Neurosurg (2009) 1.35
Arterial spin-labeling MRI can identify the presence and intensity of collateral perfusion in patients with moyamoya disease. Stroke (2011) 1.34
Molecular and magnetic resonance imaging of human embryonic stem cell-derived neural stem cell grafts in ischemic rat brain. Mol Ther (2009) 1.34
Patients beware: commercialized stem cell treatments on the web. Cell Stem Cell (2010) 1.32
Systemic augmentation of alphaB-crystallin provides therapeutic benefit twelve hours post-stroke onset via immune modulation. Proc Natl Acad Sci U S A (2011) 1.32
Risk factors of symptomatic intracerebral hemorrhage after tPA therapy for acute stroke. Stroke (2007) 1.29
Aneurysmal subarachnoid hemorrhage in patients with Hunt and Hess grade 4 or 5: treatment using the Guglielmi detachable coil system. AJNR Am J Neuroradiol (2003) 1.27
Mild hypothermia reduces apoptosis of mouse neurons in vitro early in the cascade. J Cereb Blood Flow Metab (2002) 1.21
Intracranial angioplasty without stenting for symptomatic atherosclerotic stenosis: long-term follow-up. AJNR Am J Neuroradiol (2005) 1.20
Suppression of deltaPKC activation after focal cerebral ischemia contributes to the protective effect of hypothermia. J Cereb Blood Flow Metab (2007) 1.17
Long-term behavioral assessment of function in an experimental model for ischemic stroke. J Neurosci Methods (2011) 1.16
New vessel formation in the central nervous system during tumor growth, vascular malformations, and Moyamoya. Curr Neurovasc Res (2006) 1.14
Potential of stem/progenitor cells in treating stroke: the missing steps in translating cell therapy from laboratory to clinic. Regen Med (2008) 1.13
Gene transfer of HSP72 protects cornu ammonis 1 region of the hippocampus neurons from global ischemia: influence of Bcl-2. Ann Neurol (2002) 1.12
Biphasic cytochrome c release after transient global ischemia and its inhibition by hypothermia. J Cereb Blood Flow Metab (2005) 1.12
DeltaPKC mediates microcerebrovascular dysfunction in acute ischemia and in chronic hypertensive stress in vivo. Brain Res (2007) 1.11
Crossed cerebellar diaschisis in status epilepticus. Neurocrit Care (2010) 1.10
Efficacy of endovascular stenting in dural venous sinus stenosis for the treatment of idiopathic intracranial hypertension. Neurosurg Focus (2009) 1.10
Multimodality treatment of giant intracranial arteriovenous malformations. Neurosurgery (2003) 1.10
Evaluation of surgical techniques for neuronal cell transplantation used in patients with stroke. Cell Transplant (2004) 1.09
Deep arteriovenous malformations of the basal ganglia and thalamus: natural history. J Neurosurg (2003) 1.08
Intravascular cell replacement therapy for stroke. Neurosurg Focus (2008) 1.07
Mouse model of focal cerebral ischemia using endothelin-1. J Neurosci Methods (2008) 1.06
Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation. Nat Immunol (2013) 1.05
The CCR2/CCL2 interaction mediates the transendothelial recruitment of intravascularly delivered neural stem cells to the ischemic brain. Stroke (2011) 1.05
Surgical and endovascular management of symptomatic posterior circulation fusiform aneurysms. J Neurosurg (2007) 1.05
Glycogen synthase kinase 3beta inhibitor Chir025 reduces neuronal death resulting from oxygen-glucose deprivation, glutamate excitotoxicity, and cerebral ischemia. Exp Neurol (2004) 1.04
Effect of moyamoya disease on neuropsychological functioning in adults. Neurosurgery (2008) 1.04
Stem cells and stroke: opportunities, challenges and strategies. Expert Opin Biol Ther (2011) 1.04
Pathophysiology and genetic factors in moyamoya disease. Neurosurg Focus (2009) 1.04
epsilonPKC confers acute tolerance to cerebral ischemic reperfusion injury. Neurosci Lett (2008) 1.04
Neurocognitive impairment in adults with moyamoya disease without stroke. Neurosurgery (2012) 1.03
Cavernous malformation of brainstem, thalamus, and basal ganglia: a series of 176 patients. Neurosurgery (2013) 1.03
Conditions of protection by hypothermia and effects on apoptotic pathways in a rat model of permanent middle cerebral artery occlusion. J Neurosurg (2007) 1.03
Neurosurgical advances in the treatment of moyamoya disease. Stroke (2011) 1.02
Effects of mild hypothermia on superoxide anion production, superoxide dismutase expression, and activity following transient focal cerebral ischemia. Neurobiol Dis (2002) 1.02
Dopaminergic neurons from midbrain-specified human embryonic stem cell-derived neural stem cells engrafted in a monkey model of Parkinson's disease. PLoS One (2012) 1.02
Assessment of outcome following decompressive craniectomy for malignant middle cerebral artery infarction in patients older than 60 years of age. Neurosurg Focus (2009) 1.01
Netrin-4 enhances angiogenesis and neurologic outcome after cerebral ischemia. J Cereb Blood Flow Metab (2008) 1.00
Cortical ependymoma. A case report and review. Pediatr Neurosurg (2003) 1.00
Loss of BRCC3 deubiquitinating enzyme leads to abnormal angiogenesis and is associated with syndromic moyamoya. Am J Hum Genet (2011) 0.99
Positron emission tomography imaging of poststroke angiogenesis. Stroke (2008) 0.99
Transplantation of human central nervous system stem cells - neuroprotection in retinal degeneration. Eur J Neurosci (2012) 0.99
Distinctive effects of T cell subsets in neuronal injury induced by cocultured splenocytes in vitro and by in vivo stroke in mice. Stroke (2012) 0.99
Patients with moyamoya disease presenting with movement disorder. J Neurosurg Pediatr (2010) 0.99
FasL shedding is reduced by hypothermia in experimental stroke. J Neurochem (2008) 0.99
Prognosis after cardiac arrest and hypothermia: a new paradigm. Curr Neurol Neurosci Rep (2011) 0.98
Functional engraftment of the medial ganglionic eminence cells in experimental stroke model. Cell Transplant (2009) 0.98
Central nervous system stem cell transplantation for children with neuronal ceroid lipofuscinosis. J Neurosurg Pediatr (2013) 0.98
Epsilon PKC may contribute to the protective effect of hypothermia in a rat focal cerebral ischemia model. Stroke (2007) 0.98
Potential of adult neural stem cells in stroke therapy. Regen Med (2008) 0.98
Radiation therapy for intracranial germ cell tumors. Int J Radiat Oncol Biol Phys (2003) 0.98
Mild postischemic hypothermia prolongs the time window for gene therapy by inhibiting cytochrome C release. Stroke (2004) 0.97
Quantitative hemodynamic studies in moyamoya disease: a review. Neurosurg Focus (2009) 0.97
Proteomic biomarker discovery in cerebrospinal fluid for cerebral vasospasm following subarachnoid hemorrhage. J Stroke Cerebrovasc Dis (2010) 0.96
Mild hypothermia attenuates cytochrome c release but does not alter Bcl-2 expression or caspase activation after experimental stroke. J Cereb Blood Flow Metab (2002) 0.96
Hypothermia blocks beta-catenin degradation after focal ischemia in rats. Brain Res (2008) 0.96
Cerebral myiasis associated with angiosarcoma of the scalp: case report. Neurosurgery (2007) 0.95
The basilar artery international cooperation study (BASICS). Int J Stroke (2007) 0.94
MRI profile of the perihematomal region in acute intracerebral hemorrhage. Stroke (2010) 0.94
Imaging neural stem cell graft-induced structural repair in stroke. Cell Transplant (2013) 0.94
Natural history and prognostic value of corticospinal tract Wallerian degeneration in intracerebral hemorrhage. J Am Heart Assoc (2013) 0.93
Prevalence and clinical demographics of cerebral salt wasting in patients with aneurysmal subarachnoid hemorrhage. Pituitary (2009) 0.92
Hemorrhage rate in patients with Spetzler-Martin grades IV and V arteriovenous malformations: is treatment justified? Stroke (2006) 0.91
Stem cell therapy for acute cerebral injury: what do we know and what will the future bring? Curr Opin Neurol (2013) 0.91
Profiles of neurological outcome prediction among intensivists. Neurocrit Care (2009) 0.91
Revascularization of the posterior circulation. Skull Base (2005) 0.91